Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients.

Diabetes Research and Clinical Practice
Alicia J JenkinsJian-Xing Ma

Abstract

Serum PEDF levels (mean (S.D.)) were increased in 96 Type 2 diabetic vs. 54 non-diabetic subjects; 5.3 (2.8) vs. 3.2 (2.0)mug/ml, p<0.001. In diabetes, PEDF correlated with BMI, serum creatinine and LDL-cholesterol, but not with other lipids, HbA1c or CRP. PEDF did not differ by drugs, complications, or gender.

References

Aug 2, 2003·Nature Reviews. Neuroscience·Joyce Tombran-Tink, Colin J Barnstable
Mar 9, 2006·The Journal of Clinical Endocrinology and Metabolism·Sho-Ichi YamagishiTsutomu Imaizumi
Jan 11, 2007·The Journal of Clinical Endocrinology and Metabolism·Nahoko OgataMiyo Matsumura

❮ Previous
Next ❯

Citations

Nov 29, 2011·Archives of Dermatological Research·Hideki NakajimaShigetoshi Sano
Jul 28, 2013·The International Journal of Biochemistry & Cell Biology·Zhiyu DaiGuoquan Gao
Dec 17, 2009·Molecular & Cellular Proteomics : MCP·Elizabeth YohannesMark R Chance
Oct 8, 2009·American Journal of Physiology. Endocrinology and Metabolism·Min WangSarah X Zhang
Aug 30, 2012·The Journal of Clinical Endocrinology and Metabolism·Kyle L SunderlandKevin R Short
Jun 21, 2012·Molecular Medicine·Sangeeta S ChavanKevin J Tracey
Feb 3, 2016·Journal of Clinical & Translational Endocrinology·Andrew W GardnerWilliam E Sonntag
Feb 15, 2011·European Journal of Clinical Investigation·Alexander TschonerChristoph F Ebenbichler
Jan 18, 2012·Clinical Endocrinology·Safak AkınAlper Gürlek
Apr 23, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·S PekC F Sum
Mar 8, 2016·Expert Review of Clinical Immunology·Barbara TolussoElisa Gremese
May 26, 2015·Metabolism: Clinical and Experimental·Kuppan KaviarasanNarayanasamy Angayarkanni
Dec 3, 2014·Molecular and Cellular Endocrinology·Revathy CarnagarinCrispin R Dass
Feb 25, 2014·Journal of Diabetes and Its Complications·Alicia J JenkinsUNKNOWN VADT investigators
Apr 19, 2015·Journal of Translational Medicine·Hao ZhangHongyan Dong
Jul 9, 2009·Cell Metabolism·Seamus CroweMatthew J Watt
Nov 27, 2014·Frontiers in Immunology·Elisa GremeseGianfranco Ferraccioli
Jul 19, 2013·Mediators of Inflammation·Silja Raschke, Jürgen Eckel
Jun 18, 2016·Frontiers in Physiology·Priyia PusparajahKhalid Abdul Kadir
Jan 24, 2017·Developmental and Comparative Immunology·Zhou YangLi-Qiao Chen
Jul 31, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Elizabeth P MoranJian-Xing Ma
Oct 13, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·S FamullaJ Eckel
Jan 16, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J M Moreno-NavarreteJ M Fernández-Real
Aug 21, 2018·The Journal of Physiology·Conor WillsonAyako Makino
Jun 25, 2016·Molecular Medicine·LaQueta K HudsonSangeeta S Chavan
Aug 22, 2009·Expert Opinion on Therapeutic Targets·Kathrin RychliJohann Wojta
Mar 27, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Annika TaubeJuergen Eckel
Mar 21, 2019·Current Pharmaceutical Design·Sho-Ichi YamagishiMinoru Yagi
Jul 16, 2010·The Journal of Clinical Endocrinology and Metabolism·Mònica SabaterJosé Manuel Fernández-Real

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.